Raissa Borges Curtarelli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Raissa Borges Curtarelli has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Ariadne Cristiane Cabral Cruz
Centre for Dental Implants Research, Federal University of Santa Catarina, Florianópolis 88040-900, SC, Brazil
2 shared publications - Cesar Augusto Magalhães Benfatti
Post-Graduation Program of Dentistry, Center for Education and Research on Dental Implants, Federal University of Santa Catarina, Florianópolis, Brazil
2 shared publications - Mariane Beatriz Sordi
Centre for Craniofacial and Regenerative Biology, Faculty of Dentistry, Oral & Craniofacial Sciences, Guy’s Hospital, King’s College London, London SE1 9RT, UK
2 shared publications - Gislaine Fongaro
Laboratory of Applied Virology, Department of Microbiology, Immunology, and Parasitology, Federal University of Santa Catarina, Florianópolis 88035-972, Brazil
1 shared publication - Izabella Thaís Silva
Universidade Federal de Santa Catarina
1 shared publication Lenin Proaño Minaca
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 19 January 2021
- Published by Springer Nature in Journal of Materials Science: Materials in Medicine
- Vol. 32 (1) , 1-9
Effect of dexamethasone as osteogenic supplementation in in vitro osteogenic differentiation of stem cells from human exfoliated deciduous teeth
In in vitro culture systems, dexamethasone (DEX) has been applied with ascorbic acid (ASC) and β-glycerophosphate (βGLY) as culture media supplementation to induce osteogenic differentiation of mesenchymal stem cells. However, there are some inconsistencies regarding the role of DEX as osteogenic media supplementation. Therefore, this study verified the influence of DEX culture media supplementation on the osteogenic differentiation, especially the capacity to mineralize the extracellular matrix of stem cells from human exfoliated deciduous teeth (SHED). Five groups were established: G1—SHED + Dulbecco’s Modified Eagles’ Medium (DMEM) + fetal bovine serum (FBS); G2—SHED + DMEM + FBS + DEX; G3—SHED + DMEM + FBS + ASC + βGLY; G4—SHED + DMEM + FBS + ASC + βGLY + DEX; G5—MC3T3-E1 + α Minimal Essential Medium (MEM) + FBS + ASC + βGLY. DNA content, alkaline phosphatase (ALP) activity, free calcium quantification in the extracellular medium, and extracellular matrix mineralization quantification through staining with von Kossa, alizarin red, and tetracycline were performed on days 7 and 21. Osteogenic media supplemented with ASC and β-GLY demonstrated similar effects on SHED in the presence or absence of DEX for DNA content (day 21) and capacity to mineralize the extracellular matrix according to alizarin red and tetracycline quantifications (day 21). In addition, the presence of DEX in the osteogenic medium promoted less ALP activity (day 7) and extracellular matrix mineralization according to the von Kossa assay (day 21), and more free calcium quantification at extracellular medium (day 21). In summary, the presence of DEX in the osteogenic media supplementation did not interfere with SHED commitment into mineral matrix depositor cells. We suggest that DEX may be omitted from culture media supplementation for SHED osteogenic differentiation in vitro studies.
- 19 January 2021
- Published by Springer Nature in Journal of Materials Science: Materials in Medicine
- Vol. 32 (1) , 1-9
Top Cited PapersOpen AccessEffect of dexamethasone as osteogenic supplementation in in vitro osteogenic differentiation of stem cells from human exfoliated deciduous teeth
In in vitro culture systems, dexamethasone (DEX) has been applied with ascorbic acid (ASC) and β-glycerophosphate (βGLY) as culture media supplementation to induce osteogenic differentiation of mesenchymal stem cells. However, there are some inconsistencies regarding the role of DEX as osteogenic media supplementation. Therefore, this study verified the influence of DEX culture media supplementation on the osteogenic differentiation, especially the capacity to mineralize the extracellular matrix of stem cells from human exfoliated deciduous teeth (SHED). Five groups were established: G1—SHED + Dulbecco’s Modified Eagles’ Medium (DMEM) + fetal bovine serum (FBS); G2—SHED + DMEM + FBS + DEX; G3—SHED + DMEM + FBS + ASC + βGLY; G4—SHED + DMEM + FBS + ASC + βGLY + DEX; G5—MC3T3-E1 + α Minimal Essential Medium (MEM) + FBS + ASC + βGLY. DNA content, alkaline phosphatase (ALP) activity, free calcium quantification in the extracellular medium, and extracellular matrix mineralization quantification through staining with von Kossa, alizarin red, and tetracycline were performed on days 7 and 21. Osteogenic media supplemented with ASC and β-GLY demonstrated similar effects on SHED in the presence or absence of DEX for DNA content (day 21) and capacity to mineralize the extracellular matrix according to alizarin red and tetracycline quantifications (day 21). In addition, the presence of DEX in the osteogenic medium promoted less ALP activity (day 7) and extracellular matrix mineralization according to the von Kossa assay (day 21), and more free calcium quantification at extracellular medium (day 21). In summary, the presence of DEX in the osteogenic media supplementation did not interfere with SHED commitment into mineral matrix depositor cells. We suggest that DEX may be omitted from culture media supplementation for SHED osteogenic differentiation in vitro studies.
- Open Access
- 28 August 2019
- Published by Morressier GmbH
Osteogenic capacity of PLGA embedding simvastatin for biofunctionalization of titanium abutments
Background: Even though the high success rate of oral rehabilitations using dental implants, the periimplant bone loss can still be observed. Biomaterials have been studied with incorporation of drugs that can be released locally and help the process of biological reestablishment and periimplant tissue maintenance. To obtain a greater marginal stability, a titanium surface coating
- 28 August 2019
- Published by Morressier GmbH
Open AccessOsteogenic capacity of PLGA embedding simvastatin for biofunctionalization of titanium abutments
Background: Even though the high success rate of oral rehabilitations using dental implants, the periimplant bone loss can still be observed. Biomaterials have been studied with incorporation of drugs that can be released locally and help the process of biological reestablishment and periimplant tissue maintenance. To obtain a greater marginal stability, a titanium surface coating